ADM’s Fibersol gains TGA approval for use in biologicals, supplements
Fibersol may delay hunger, support the production of appetite-regulating hormones such as GLP-1 and peptide YY.
AUSTRALIA – ADM has announced that its Fibersol® line of soluble prebiotic fibers has received approval from the Therapeutic Goods Administration (TGA) for use as an active ingredient in biologicals, listed medicines, and prescription medicines.
This regulatory milestone expands Fibersol’s role beyond conventional food and beverage applications into dietary supplements and regulated health products.
Helen Hu, President of Health & Wellness APAC at ADM, described the approval as a pivotal achievement for the company’s global nutrition strategy.
“Securing TGA approval for Fibersol marks a significant development for ADM,” she said.
“It allows our customers to highlight Fibersol’s clinically supported health benefits on packaging, providing clear value in a category where consumer trust is essential. In today’s dynamic health and wellness market, regulatory approvals are more than a requirement; they are a mark of credibility.”
Fibersol has been extensively studied, with more than 100 scientific publications demonstrating its contribution to digestive health and metabolic support.
Clinical evidence shows that it promotes the growth of beneficial gut bacteria, supports microbiota balance, and helps maintain a healthy intestinal environment.
Research also indicates that Fibersol may delay hunger, support the production of appetite-regulating hormones such as GLP-1 and peptide YY, and reduce absorption of dietary sugars and triglycerides.
Beyond its clinically supported benefits, Fibersol is valued for its technical versatility.
It remains stable under heat, acidity, shear, and freeze/thaw conditions, while its neutral taste allows seamless incorporation across a variety of formats.
In the food and beverage industry, Fibersol has been widely used in bakery, dairy, beverages, and confectionery products to enhance fiber content, support digestive wellness, and deliver better nutritional profiles without compromising taste or texture.
The Australian prebiotics market is projected to grow at a compound annual growth rate (CAGR) of 17.6% from 2024 to 2030, driven by increasing consumer interest in digestive health.
Nearly 40% of Australians have taken steps to improve their gut health in the past year, with more than one-third turning to supplements and vitamins as part of this shift toward targeted, science-backed solutions.
ADM’s TGA approval for Fibersol positions the company strongly within this high-growth sector.
This development builds on ADM’s growing portfolio of TGA-recognized ingredients, following the approval of DE111™ in 2024.
It also comes on the heels of Fibersol being named Best Functional Ingredient of the Decade at the 2024 Gulfood Manufacturing Industry Excellence Awards, further reinforcing its status as a clinically backed, industry-leading solution for digestive wellness.
Sign up HERE to receive our email newsletters with the latest news and insights from Africa and around the world, and follow us on our WhatsApp channel for updates.
